Hepatitis Monthly

Published by: Kowsar

Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North Cyprus

Meryem Güvenir 1 , * , Emrah Guler 2 , Deren Oygar 3 , Ahmet Behlul 3 and Kaya Suer 4
Authors Information
1 Department of Microbiology, Vocational School of Health Services, Near East University, Nicosia, Cyprus
2 Department of Microbiology, Faculty of Medicine, Near East University, Nicosia, Cyprus
3 Department of Nephrology, Faculty of Medicine, Nicosia, Cyprus
4 Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia, Cyprus
Article information
  • Hepatitis Monthly: January 31, 2019, 19 (1); e84699
  • Published Online: January 12, 2019
  • Article Type: Research Article
  • Received: September 28, 2018
  • Revised: December 6, 2018
  • Accepted: December 14, 2018
  • DOI: 10.5812/hepatmon.84699

To Cite: Güvenir M, Guler E, Oygar D, Behlul A, Suer K. Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North Cyprus, Hepat Mon. 2019 ; 19(1):e84699. doi: 10.5812/hepatmon.84699.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Kamal IMA, Mahdi BM. Seroprevalence occurrence of viral hepatitis and HIV among hemodialysis patients. Ann Med Surg (Lond). 2018;29:1-4. doi: 10.1016/j.amsu.2018.03.018. [PubMed: 29692888]. [PubMed Central: PMC5911664].
  • 2. Yadegarynia D, Hatamai H, Roodsari SR, Arab-Mazar Z. Seroprevalence of hepatitis B, C and D viral among hemodialysis patients in Tehran. Iran J Microbiol. 2017;9(3):195-9. [PubMed: 29225759]. [PubMed Central: PMC5719514].
  • 3. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of hepatitis viruses B, C, D and HIV Infection among hemodialysis patients in Kerman province, south-east Iran. Hepat Mon. 2012;12(5):339-43. doi: 10.5812/hepatmon.5969. [PubMed: 22783346]. [PubMed Central: PMC3389360].
  • 4. Senosy SA, El Shabrawy EM. Hepatitis C virus in patients on regular hemodialysis in Beni-Suef Governorate, Egypt. J Egypt Public Health Assoc. 2016;91(2):86-9. doi: 10.1097/01.EPX.0000484091.57255.c0. [PubMed: 27455086].
  • 5. Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World J Gastroenterol. 2017;23(1):151-66. doi: 10.3748/wjg.v23.i1.151. [PubMed: 28104991]. [PubMed Central: PMC5221279].
  • 6. Abdalhafeez AM, Khalid AE, Osama MK, Mohammed OH, Abdel Rahim MEH, Isam ME. Prevalence of occult hepatitis B virus (HBV) infections in haemodialysis patients in Khartoum State, Sudan from 2012 to 2014. J Med Lab Diagno. 2015;6(4):22-6. doi: 10.5897/jmld2015.0099.
  • 7. Daglar D, Ergani A, Demirbakan H, Ozhak Baysan B, Ongut G, Kocak H, et al. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients]. Mikrobiyol Bul. 2014;48(1):143-50. Turkish. [PubMed: 24506725].
  • 8. Arabacı F, Oldacay M. [Hepatitis B,C seroprevalence and chronicity rates for hepatitis in patients treated by different dialysis centers in Çanakkale province, Turkey]. Türk Hijyen ve Deneysel Biyoloji Dergisi. 2009;66(4):161-7. Turkish.
  • 9. Suer HK, Guvenir M, Guler E, Diktas H. Evaluation of HBsAg, anti-HCV, anti-HIV and syphilis test results among the blood donors admitted to the Near East University Hospital in Turkish Republic of Northern Cyprus. Klimik Dergisi/Klimik J. 2014;25(3):99-102. doi: 10.5152/kd.2012.28.
  • 10. Arikan A, Sanlidag T, Suer K, Sayan M, Akcali S, Guler E. [Molecular epidemiology of hepatitis B virus in Northern Cyprus]. Mikrobiyol Bul. 2016;50(1):86-93. Turkish. [PubMed: 27058332].
  • 11. Kaptanoğlu AF, Süer K, Diktaş H, Hinçal E. Knowledge, attitudes and behaviour towards sexually transmitted diseases in Turkish Cypriot adolescents. Cent Eur J Public Health. 2013;21(1):54-8.
  • 12. Djalalinia S, Ramezan Ghorbani N, Tajbakhsh R, Modirian M, Esmaeili Abdar Z, Mahdavi Gorabi A, et al. Hepatitis B virus infection in Iranian hemodialysis patients: A systematic review and meta-analysis. Iran J Kidney Dis. 2018;12(1):1-9. [PubMed: 29421769].
  • 13. Süleymanlar G, Ateş K, Seyahi N. Registry of the nephrology, dialysis and transplantation in Turkey. 2017. 16 p.
  • 14. Halle MP, Choukem SP, Kaze FF, Ashuntantang G, Tchamago V, Mboue-Djieka Y, et al. Hepatitis B, hepatitis C, and human immune deficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance hemodialysis in Cameroon. Iran J Kidney Dis. 2016;10(5):304-9. [PubMed: 27721229].
  • 15. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol. 2012;84(1):52-5. doi: 10.1002/jmv.22256. [PubMed: 22052648].
  • 16. Shamsdin SA, Sepehrimanesh M, Pezeshki B, Nejabat M. Seroprevalence of hepatitis B and C in patients with hemophilia: A single-centre descriptive study. Shiraz E-Med J. 2015;16(7). doi: 10.17795/semj24573.
  • 17. Zare F, Fattahi MR, Sepehrimanesh M, Safarpour AR. Economic burden of hepatitis C virus infection in different stages of disease: A report from southern Iran. Hepat Mon. 2016;16(4). e32654. doi: 10.5812/hepatmon.32654. [PubMed: 27257424]. [PubMed Central: PMC4887962].
  • 18. Di Napoli A, Pezzotti P, Di Lallo D, Petrosillo N, Trivelloni C, Di Giulio S, et al. Epidemiology of hepatitis C virus among long-term dialysis patients: A 9-year study in an Italian region. Am J Kidney Dis. 2006;48(4):629-37. doi: 10.1053/j.ajkd.2006.07.004. [PubMed: 16997059].
  • 19. Crounce AM, Bouchardeau F, Chauveau P, Le Marrec N, Girault A, Zins B, et al. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transpl. 1995. doi: 10.1093/ndt/10.2.234.
  • 20. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int. 2004;65(6):2335-42. doi: 10.1111/j.1523-1755.2004.00649.x. [PubMed: 15149347].
  • 21. Afshari R, Fattahi MR, Sepehrimanesh M, Safarpour AR, Nejabat M, Dehghani SM, et al. The seroepidemiology of hepatitis c infection in drug abusers referring to Shiraz drug rehabilitation centers. Govaresh. 2016;21(3):188-92.
  • 22. Lankarani KB, Ardebili M, Sepehrimanesh M, Nejabat M, Hemmati Rad MA, Hosseini SY. Evaluation of hepatitis C virus intrafamilial transmission among families with one index case, a pilot study from Fars province, Iran. Gastroenterol Hepatol Bed Bench. 2016;9(4):250-8. [PubMed: 27895850]. [PubMed Central: PMC5118849].
  • 23. Fattahi MR, Safarpour A, Sepehrimanesh M, Hosseini Asl SM, Mohamaddoust F. The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran. Hepat Mon. 2015;15(2). e24734. doi: 10.5812/hepatmon.24734. [PubMed: 25788957]. [PubMed Central: PMC4350250].
  • 24. World Health Organization. HIV/AIDS. 2019. Available from: www.who.int/hiv/data/en.
  • 25. Alavian SM. A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol. 2009;15(6):641-6. [PubMed: 19222088]. [PubMed Central: PMC2653433].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments